2023-01-012023-12-312023-12-31false13636290MARKEATON HEALTHCARE LTD2024-08-2347730iso4217:GBPxbrli:pure136362902023-01-01136362902023-12-31136362902023-01-012023-12-31136362902021-09-22136362902022-12-31136362902021-09-222022-12-3113636290bus:SmallEntities2023-01-012023-12-3113636290bus:AuditExempt-NoAccountantsReport2023-01-012023-12-3113636290bus:FullAccounts2023-01-012023-12-3113636290bus:PrivateLimitedCompanyLtd2023-01-012023-12-3113636290core:WithinOneYear2023-12-3113636290core:AfterOneYear2023-12-3113636290core:WithinOneYear2022-12-3113636290core:AfterOneYear2022-12-3113636290core:ShareCapital2023-12-3113636290core:SharePremium2023-12-3113636290core:RevaluationReserve2023-12-3113636290core:OtherReservesSubtotal2023-12-3113636290core:RetainedEarningsAccumulatedLosses2023-12-3113636290core:ShareCapital2022-12-3113636290core:SharePremium2022-12-3113636290core:RevaluationReserve2022-12-3113636290core:OtherReservesSubtotal2022-12-3113636290core:RetainedEarningsAccumulatedLosses2022-12-3113636290core:LandBuildings2023-12-3113636290core:PlantMachinery2023-12-3113636290core:Vehicles2023-12-3113636290core:FurnitureFittings2023-12-3113636290core:OfficeEquipment2023-12-3113636290core:NetGoodwill2023-12-3113636290core:IntangibleAssetsOtherThanGoodwill2023-12-3113636290core:ListedExchangeTraded2023-12-3113636290core:UnlistedNon-exchangeTraded2023-12-3113636290core:LandBuildings2022-12-3113636290core:PlantMachinery2022-12-3113636290core:Vehicles2022-12-3113636290core:FurnitureFittings2022-12-3113636290core:OfficeEquipment2022-12-3113636290core:NetGoodwill2022-12-3113636290core:IntangibleAssetsOtherThanGoodwill2022-12-3113636290core:ListedExchangeTraded2022-12-3113636290core:UnlistedNon-exchangeTraded2022-12-3113636290core:LandBuildings2023-01-012023-12-3113636290core:PlantMachinery2023-01-012023-12-3113636290core:Vehicles2023-01-012023-12-3113636290core:FurnitureFittings2023-01-012023-12-3113636290core:OfficeEquipment2023-01-012023-12-3113636290core:NetGoodwill2023-01-012023-12-3113636290core:IntangibleAssetsOtherThanGoodwill2023-01-012023-12-3113636290core:ListedExchangeTraded2023-01-012023-12-3113636290core:UnlistedNon-exchangeTraded2023-01-012023-12-3113636290core:MoreThanFiveYears2023-01-012023-12-3113636290core:Non-currentFinancialInstruments2023-12-3113636290core:Non-currentFinancialInstruments2022-12-3113636290dpl:CostSales2023-01-012023-12-3113636290dpl:DistributionCosts2023-01-012023-12-3113636290core:LandBuildings2023-01-012023-12-3113636290core:PlantMachinery2023-01-012023-12-3113636290core:Vehicles2023-01-012023-12-3113636290core:FurnitureFittings2023-01-012023-12-3113636290core:OfficeEquipment2023-01-012023-12-3113636290dpl:AdministrativeExpenses2023-01-012023-12-3113636290core:NetGoodwill2023-01-012023-12-3113636290core:IntangibleAssetsOtherThanGoodwill2023-01-012023-12-3113636290dpl:GroupUndertakings2023-01-012023-12-3113636290dpl:ParticipatingInterests2023-01-012023-12-3113636290dpl:GroupUndertakingscore:ListedExchangeTraded2023-01-012023-12-3113636290core:ListedExchangeTraded2023-01-012023-12-3113636290dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-01-012023-12-3113636290core:UnlistedNon-exchangeTraded2023-01-012023-12-3113636290dpl:CostSales2021-09-222022-12-3113636290dpl:DistributionCosts2021-09-222022-12-3113636290core:LandBuildings2021-09-222022-12-3113636290core:PlantMachinery2021-09-222022-12-3113636290core:Vehicles2021-09-222022-12-3113636290core:FurnitureFittings2021-09-222022-12-3113636290core:OfficeEquipment2021-09-222022-12-3113636290dpl:AdministrativeExpenses2021-09-222022-12-3113636290core:NetGoodwill2021-09-222022-12-3113636290core:IntangibleAssetsOtherThanGoodwill2021-09-222022-12-3113636290dpl:GroupUndertakings2021-09-222022-12-3113636290dpl:ParticipatingInterests2021-09-222022-12-3113636290dpl:GroupUndertakingscore:ListedExchangeTraded2021-09-222022-12-3113636290core:ListedExchangeTraded2021-09-222022-12-3113636290dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2021-09-222022-12-3113636290core:UnlistedNon-exchangeTraded2021-09-222022-12-3113636290core:NetGoodwill2023-12-3113636290core:IntangibleAssetsOtherThanGoodwill2023-12-3113636290core:LandBuildings2023-12-3113636290core:PlantMachinery2023-12-3113636290core:Vehicles2023-12-3113636290core:FurnitureFittings2023-12-3113636290core:OfficeEquipment2023-12-3113636290core:AfterOneYear2023-12-3113636290core:WithinOneYear2023-12-3113636290core:ListedExchangeTraded2023-12-3113636290core:UnlistedNon-exchangeTraded2023-12-3113636290core:ShareCapital2023-12-3113636290core:SharePremium2023-12-3113636290core:RevaluationReserve2023-12-3113636290core:OtherReservesSubtotal2023-12-3113636290core:RetainedEarningsAccumulatedLosses2023-12-3113636290core:NetGoodwill2022-12-3113636290core:IntangibleAssetsOtherThanGoodwill2022-12-3113636290core:LandBuildings2022-12-3113636290core:PlantMachinery2022-12-3113636290core:Vehicles2022-12-3113636290core:FurnitureFittings2022-12-3113636290core:OfficeEquipment2022-12-3113636290core:AfterOneYear2022-12-3113636290core:WithinOneYear2022-12-3113636290core:ListedExchangeTraded2022-12-3113636290core:UnlistedNon-exchangeTraded2022-12-3113636290core:ShareCapital2022-12-3113636290core:SharePremium2022-12-3113636290core:RevaluationReserve2022-12-3113636290core:OtherReservesSubtotal2022-12-3113636290core:RetainedEarningsAccumulatedLosses2022-12-3113636290core:NetGoodwill2021-09-2213636290core:IntangibleAssetsOtherThanGoodwill2021-09-2213636290core:LandBuildings2021-09-2213636290core:PlantMachinery2021-09-2213636290core:Vehicles2021-09-2213636290core:FurnitureFittings2021-09-2213636290core:OfficeEquipment2021-09-2213636290core:AfterOneYear2021-09-2213636290core:WithinOneYear2021-09-2213636290core:ListedExchangeTraded2021-09-2213636290core:UnlistedNon-exchangeTraded2021-09-2213636290core:ShareCapital2021-09-2213636290core:SharePremium2021-09-2213636290core:RevaluationReserve2021-09-2213636290core:OtherReservesSubtotal2021-09-2213636290core:RetainedEarningsAccumulatedLosses2021-09-2213636290core:AfterOneYear2023-01-012023-12-3113636290core:WithinOneYear2023-01-012023-12-3113636290core:Non-currentFinancialInstrumentscore:CostValuation2023-01-012023-12-3113636290core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-01-012023-12-3113636290core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-01-012023-12-3113636290core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-01-012023-12-3113636290core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-01-012023-12-3113636290core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-01-012023-12-3113636290core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-01-012023-12-3113636290core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-01-012023-12-3113636290core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-01-012023-12-3113636290core:Non-currentFinancialInstrumentscore:CostValuation2023-12-3113636290core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-12-3113636290core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-12-3113636290core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-12-3113636290core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-12-3113636290core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-12-3113636290core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-12-3113636290core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-12-3113636290core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-12-3113636290core:Non-currentFinancialInstrumentscore:CostValuation2022-12-3113636290core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-12-3113636290core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-12-3113636290core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-12-3113636290core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-12-3113636290core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-12-3113636290core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-12-3113636290core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-12-3113636290core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-12-3113636290bus:Director12023-01-012023-12-3113636290core:FurnitureFittingsToolsEquipment2022-12-3113636290core:FurnitureFittingsToolsEquipment2023-01-012023-12-3113636290core:FurnitureFittingsToolsEquipment2023-12-31

MARKEATON HEALTHCARE LTD

Registered Number
13636290
(England and Wales)

Unaudited Financial Statements for the Year ended
31 December 2023

MARKEATON HEALTHCARE LTD
Company Information
for the year from 1 January 2023 to 31 December 2023

Director

LAKHANI, Krishan Arvind Junior

Registered Address

Markeaton Pharmacy
126 Kedleston Road
Derby
DE22 1FX

Registered Number

13636290 (England and Wales)
MARKEATON HEALTHCARE LTD
Balance Sheet as at
31 December 2023

Notes

2023

2022

£

£

£

£

Fixed assets
Intangible assets3729,623820,825
Tangible assets43,823857
733,446821,682
Current assets
Debtors6108,349141,746
Cash at bank and on hand48,14459,529
156,493201,275
Creditors amounts falling due within one year7(290,310)(391,537)
Net current assets (liabilities)(133,817)(190,262)
Total assets less current liabilities599,629631,420
Creditors amounts falling due after one year8(764,552)(653,391)
Net assets(164,923)(21,971)
Capital and reserves
Called up share capital11
Profit and loss account(164,924)(21,972)
Shareholders' funds(164,923)(21,971)
The financial statements were approved and authorised for issue by the Director on 23 August 2024, and are signed on its behalf by:
LAKHANI, Krishan Arvind Junior
Director
Registered Company No. 13636290
MARKEATON HEALTHCARE LTD
Notes to the Financial Statements
for the year ended 31 December 2023

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Intangible assets
Intangible assets are stated at cost less accumulated amortisation and accumulated impairment losses. The assets are reviewed for impairment if the above factors indicate that the carrying amount may be impaired. Amortisation is included in 'administrative expenses' in the profit and loss account.
Goodwill
Goodwill arising on an acquisition of a business is carried at cost less accumulated impairment losses, if any. Goodwill is amortised over its expected useful life which is estimated to be ten years. Goodwill is assessed for impairment when there are indicators of impairment and any impairment is charged to the income statement. No reversals of impairment are recognised.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Reducing balance (%)
Fixtures and fittings15
Vehicles20
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less. Bank overdrafts are disclosed separately. For the purpose of the cash flow statement, bank overdrafts form an integral part of the company's cash management and are included as a component of cash and cash equivalents.
2.Average number of employees

20232022
Average number of employees during the year99
3.Intangible assets

Goodwill

Total

££
Cost or valuation
At 01 January 23912,028912,028
At 31 December 23912,028912,028
Amortisation and impairment
At 01 January 2391,20391,203
Charge for year91,20291,202
At 31 December 23182,405182,405
Net book value
At 31 December 23729,623729,623
At 31 December 22820,825820,825
4.Tangible fixed assets

Vehicles

Fixtures & fittings

Total

£££
Cost or valuation
At 01 January 23-1,0081,008
Additions9,168-9,168
At 31 December 239,1681,00810,176
Depreciation and impairment
At 01 January 23-151151
Charge for year597128725
Other adjustments5,477-5,477
At 31 December 236,0742796,353
Net book value
At 31 December 233,0947293,823
At 31 December 22-857857
5.Stocks
Stock is stated at the lower of cost and net realisable value, which is the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first-in, first-out basis. Work in Progress and finished goods include labour and attributable overheads. At each reporting date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit and loss.
6.Debtors: amounts due within one year

2023

2022

££
Trade debtors / trade receivables26,401124,967
Other debtors13,63216,058
Prepayments and accrued income68,316721
Total108,349141,746
Short-term debtors are measured at a price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortisation cost using the effective interest method less any impairment.
7.Creditors: amounts due within one year

2023

2022

££
Trade creditors / trade payables108,848104,810
Bank borrowings and overdrafts174,868268,952
Taxation and social security5,84412,775
Accrued liabilities and deferred income7505,000
Total290,310391,537
Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and subsequently at amortised cost using the effective interest method.
8.Creditors: amounts due after one year

2023

2022

££
Bank borrowings and overdrafts764,552653,391
Total764,552653,391